BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Walker A, Schmitt-Kopplin P. The role of fecal sulfur metabolome in inflammatory bowel diseases. Int J Med Microbiol 2021;311:151513. [PMID: 34147944 DOI: 10.1016/j.ijmm.2021.151513] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Hang L, Wang E, Feng Y, Zhou Y, Meng Y, Jiang F, Yuan J. Metagenomics and metabolomics analysis to investigate the effect of Shugan decoction on intestinal microbiota in irritable bowel syndrome rats. Front Microbiol 2022;13. [DOI: 10.3389/fmicb.2022.1024822] [Reference Citation Analysis]
2 Zheng L. New insights into the interplay between intestinal flora and bile acids in inflammatory bowel disease. World J Clin Cases 2022; 10(30): 10823-10839 [DOI: 10.12998/wjcc.v10.i30.10823] [Reference Citation Analysis]
3 Richie TG, Heeren L, Kamke A, Pogranichniy S, Rumback K, Summers T, Wiechman H, Ran Q, Sarkar S, Plattner B, Lee STM. Limitation of sulfur-containing amino acid availability by specific bacterial populations during enhanced colitis in IBD mouse model.. [DOI: 10.1101/2022.10.03.510649] [Reference Citation Analysis]
4 Arehart CH, Sterrett JD, Garris RL, Quispe-pilco RE, Gignoux CR, Evans LM, Stanislawski MA. Poly-omic risk scores predict inflammatory bowel disease diagnosis.. [DOI: 10.1101/2022.09.14.508056] [Reference Citation Analysis]
5 Preethy S, Ikewaki N, Levy GA, Raghavan K, Dedeepiya VD, Yamamoto N, Srinivasan S, Ranganathan N, Iwasaki M, Senthilkumar R, Abraham SJK. Two unique biological response-modifier glucans beneficially regulating gut microbiota and faecal metabolome in a non-alcoholic steatohepatitis animal model, with potential applications in human health and disease. BMJ Open Gastroenterol 2022;9:e000985. [PMID: 36167455 DOI: 10.1136/bmjgast-2022-000985] [Reference Citation Analysis]
6 Popli S, Badgujar PC, Agarwal T, Bhushan B, Mishra V. Persistent organic pollutants in foods, their interplay with gut microbiota and resultant toxicity. Sci Total Environ 2022;832:155084. [PMID: 35395291 DOI: 10.1016/j.scitotenv.2022.155084] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Feng W, Liu J, Cheng H, Zhang D, Tan Y, Peng C. Dietary compounds in modulation of gut microbiota-derived metabolites. Front Nutr 2022;9:939571. [DOI: 10.3389/fnut.2022.939571] [Reference Citation Analysis]
8 Preethy S, Ikewaki N, Levy GA, Raghavan K, Dedeepiya VD, Yamamoto N, Srinivasan S, Ranganathan N, Iwasaki M, Senthilkumar R, Abraham SJ. Two unique biological response-modifier glucans beneficially regulating gut microbiota and faecal metabolome in a non-alcoholic steatohepatitis animal model, with potential for applications in human health and disease.. [DOI: 10.1101/2022.06.23.497433] [Reference Citation Analysis]
9 Biwer P, Neumann-schaal M, Henke P, Jahn D, Schulz S. Thiol Metabolism and Volatile Metabolome of Clostridioides difficile. Front Microbiol 2022;13:864587. [DOI: 10.3389/fmicb.2022.864587] [Reference Citation Analysis]
10 Haince JF, Joubert P, Bach H, Ahmed Bux R, Tappia PS, Ramjiawan B. Metabolomic Fingerprinting for the Detection of Early-Stage Lung Cancer: From the Genome to the Metabolome. Int J Mol Sci 2022;23:1215. [PMID: 35163138 DOI: 10.3390/ijms23031215] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Zhuang Z, Li N, Wang J, Yang R, Wang W, Liu Z, Huang T. GWAS-associated bacteria and their metabolites appear to be causally related to the development of inflammatory bowel disease. Eur J Clin Nutr. [DOI: 10.1038/s41430-022-01074-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Khalkhal E, Rezaei-Tavirani M, Fathi F, Nobakht M Gh BF, Taherkhani A, Rostami-Nejad M, Asri N, Haidari MH. Screening of Altered Metabolites and Metabolic Pathways in Celiac Disease Using NMR Spectroscopy. Biomed Res Int 2021;2021:1798783. [PMID: 34820452 DOI: 10.1155/2021/1798783] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Iyer N, Corr SC. Gut Microbial Metabolite-Mediated Regulation of the Intestinal Barrier in the Pathogenesis of Inflammatory Bowel Disease. Nutrients 2021;13:4259. [PMID: 34959809 DOI: 10.3390/nu13124259] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
14 Aldars-García L, Gisbert JP, Chaparro M. Metabolomics Insights into Inflammatory Bowel Disease: A Comprehensive Review. Pharmaceuticals (Basel) 2021;14:1190. [PMID: 34832973 DOI: 10.3390/ph14111190] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]